Implications of surprise billing for the health sector

While legislation addressing COVID-19 continues to be at the forefront of Congress’ agenda, issues such as surprise billing are still critical.

Contact Ernst & Young LLP to discuss implications of health policy regulations and legislations.

The Health practice within Washington Council Ernst & Young (WCEY) offers professional services that leverage health- and life science-specific knowledge with timely, relevant, and customized legislative consulting services.

While legislation addressing COVID-19 continues to be at the forefront of congressional agendas, other pre-COVID-19 priorities, such as surprise billing, price transparency and data interoperability are expected to garner new focus.

Congress continues to push to stop surprise medical billing, one of a handful of health care issues that enjoy bipartisan support. Fueled by voter concern and the news media — highlighting Americans hit with surprise emergency room bills and cost of supplies being well over market value, congressional leaders are intent on moving legislation to address the problem.

The EY Health policy professionals are poised to help organizations navigate the changing regulatory environment.

What consistent structures is Congress discussing around surprise billing?

Congress wants to stop surprise medical bills

Addressing “surprise billing” is a potentially achievable win in the complex landscape of addressing runaway health care costs.

Learn more

Surprise billing legislation advances

Surprise billing and hospice bills enjoyed sweeping bipartisan support

Learn more

Health policy news alerts

In today's complex and rapidly changing policy and tax environment, keeping up to date on key developments has never been more challenging. Sign up to receive the latest health and life sciences sector-specific policy news updates.

Subscribe